Filing Flows › Comparisons › HROW vs RYTM
Harrow vs Rhythm Pharmaceuticals: HROW and RYTM compared
Harrow is the larger company: $99.3M of revenue in its latest quarter (Q3 2026) against $92.1M for Rhythm Pharmaceuticals (Q3 2026). Rhythm Pharmaceuticals is growing faster (+80% against +39% a year earlier). Harrow is more profitable, with an operating margin of 11.6% against -42.6%.
Where the money goes: HROW and RYTM
Harrow (HROW) · Q3 2026
Harrow, Q3 2026: revenue $99.3M (+39% year over year), operating margin 11.6%, net earnings $9.8M. The chart follows the revenue to costs, profit and cash.
Rhythm Pharmaceuticals (RYTM) · Q3 2026
Rhythm Pharmaceuticals, Q3 2026: revenue $92.1M (+80% year over year), operating margin -42.6%, net loss $41.4M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Harrow (HROW) | Rhythm Pharmaceuticals (RYTM) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $99.3M | $92.1M |
| Revenue growth, Y/Y | +39% | +80% |
| Gross margin | 75.4% | — |
| Operating margin | 11.6% | -42.6% |
| Net earnings | $9.8M | −$41.4M |
| Net margin | 9.8% | -44.9% |
| Operating cash flow | — | −$3.1M |
Questions
Which is bigger, Harrow or Rhythm Pharmaceuticals?
Harrow is the larger company: $99.3M of revenue in its latest quarter (Q3 2026) against $92.1M for Rhythm Pharmaceuticals (Q3 2026).
Is Harrow or Rhythm Pharmaceuticals growing faster?
Rhythm Pharmaceuticals is growing faster (+80% against +39% a year earlier).
Which is more profitable, Harrow or Rhythm Pharmaceuticals?
Harrow is more profitable, with an operating margin of 11.6% against -42.6%.
More: Harrow earnings · how Harrow makes money · Rhythm Pharmaceuticals earnings · how Rhythm Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (8-K filed Nov 9, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.